Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Anti-platelet therapy: ADP receptor antagonists.

Wijeyeratne, YD; Heptinstall, S (2011) Anti-platelet therapy: ADP receptor antagonists. British Journal of Clinical Pharmacology, 72 (4). 647 - 657. ISSN 0306-5251
SGUL Authors: Wijeyeratne, Yanushi Dullewe

PDF Published Version
Download (1MB) | Preview


The P2Y(12) receptor on platelets with which ADP interacts has an important role in promoting platelet function and thereby platelet involvement in both haemostasis and thrombosis. Agents that act as antagonists at this receptor are thus likely to provide effective antithrombotic therapy, provided that there are no adverse effects on haemostasis. Here we describe the ADP receptor antagonists that are available and in development. We also consider their mode of action and ask whether there are additional mechanisms through which they exert their inhibitory effects on platelet function.

Item Type: Article
Additional Information: © 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society. Re-use of this article is permitted in accordance with the Terms and Conditions set out at
Keywords: Blood Platelets, Humans, Platelet Aggregation, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists, Thrombosis
Journal or Publication Title: British Journal of Clinical Pharmacology
ISSN: 0306-5251
1 October 2011Published
PubMed ID: 21518389
Web of Science ID: 21518389
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Go to PubMed abstract
Publisher's version:


Item downloaded times since 06 Oct 2014.

Actions (login required)

Edit Item Edit Item